Upcoming OOO | | |
Lyme LIVD File/SCT hierarchy Question | Christina | Genbio Immunodot Borrelia (Lyme) with Recombinant Protein assay Regenstrief wants to create a generic code with the following parts: Borrelia sp Ab | Prid | Pt | Ser | Nom | IA Would these codes as a substance hierarchy be appropriate as normally we have created these kind of results in the clinical finding hierarchy, since the package insert includes “detected” and “not detected” in the antibody specific terms Proposal from US, Australia and Europe on the table to avoid having to map to the orgnism hierarchy - creating attribute link between substance to organism will be availalbe in the future (so that we no longer need to just map to organism)
|
Specimen CMT - SCT submission terms | John | bodyfluid from insertion site resolution - did Nancy’s answer from last week resolve this? can get fluid or tissue from the pacemaker pocket will create a pacemaker specific term for body fluid and one for tissue from pacemaker insertion site or pacemaker pocket? - a pocket concept does not exist in SCT, would be modeled using SNOMED also has pacemaker and pacemaker lead (would probably also have tissue on it (will be put in broth culture) as specimen (which when taken out, received at pathology lab and then forwarded to the manufacturer) What about the medication port (bubble under the skin to administer recurring medication for example for cancer patients) - do we have a term for that? Postcall note from John: Looking at the references provided, one reference identified a group of devices as “Cardiac implantable electronic devices” and this caught my eye. The following concept was added to SNOMED in 2021: 1162882002 |Cardiac implantable electronic device pocket (morphologic abnormality)| I am proposing that we change the concept requests from specifying the pacemaker to be more generic as follows:
Christina will share the question word document with Nancy,so she can do research before the next call Clotactivator substance - modeled as a subtyp of coagulant Cyto-Chex term looks ok (will add sysnonym without the registered trademark sign Phytohemagglutinin (substance) - is for SPM-6 (is part of the kit for the Quantiferon GOLD test)
|
Creating Value Sets for specimen related attributes | John | |
Call Adjourned | | Next call is June 26th, 2025 |
LOINC common maps | Not discussed | |
Previous Action Items | Not discussed | |
Specimen CMT - Hosting Options | Not discussed | How can we publish the content in the dB? SNOMED CT Extension and use of RefSets (start with VSAC value sets as proof of concept and then migrate over) to indicate: How do we decide what format to share this in - get input from EHR-s and LIS vendors: Write letter of mulitple stakeholders to request EHR-s and LIS vendors to implement indicating that this is a patient safety issue, as incorrect Abx treatment will contribute to multi-drug resistance (use CTSI findings to provide background) focus on blood, urine, wound cultures (get data from NHSN, too)
Nancy is talking to DHQP about the linkage with specimen collection While we have HIT certification that is for the EHR-s there is currently no enforcement for implementation at the organizations need C-suite buy-in Professional organizations - like CAP and ACOS and AJCC get them to write the synoptic reports (better structuring of data) - for surgical aspects - similar to what CAP has done for Cancer (though they do not have the SCT codes included in the past - may be including SNOMED CT starting in 2025, but they are also using the SCT codes for observables) Synoptic reporting for cancer surgery: Current requirements and future state: The four CoC accreditation standards that include synoptic operative reporting requirements apply to sentinel lymph node biopsy for breast cancer (Standard 5.3), axillary lymph node dissection for breast cancer (Standard 5.4), wide local excision for primary cutaneous melanoma (Standard 5.5), and colonic resection for colon cancer (Standard 5.6). These accreditation standards were developed from the evidence-based recommendations for cancer surgery detailed in the Operative Standards for Cancer Surgery manuals.7,8 try to get AMA support to get providers to adopt this Reach out to IDSA, too
|
Specimen CMT pilot implementers | Not discussed | |
Specimen CMT - education | Not discussed | Need education for providers and IT folks that helps with set up of the EHR-S / LIS configuration -this can be supported / accomplished? with the Implementaiton Guide we could write if we have a use case of how a patient is impacted on their journey through the healthcare system - CAP created a nice video that showed how patient care was affected by incorrect data SHIELD FDA BAA Year 2
|
Specimen CMT - tracking implementation impact Setting baseline Define metrics
| Not discussed | |
Specimen CMT - Compare to NHS Medical Terminology testing | Not discussed | Will get updated vocab at a later date |
Future projects for this call after CMT | Not discussed | |
